Pillstats
Rx only · Injection, Solution · Intravenous

Metronidazole

Metronidazole

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US10 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6922
US makers9 labelers
Packages10
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.7K9.4K14K19K2025 Q12025 Q22025 Q32025 Q42026 Q1
9.5K
Rx · 2026 Q1
1.4M
Units dispensed
-42%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Baxter Healthcare Corporationunknown2SUPPLYING
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown1SUPPLYING
Sagent Pharmaceuticalsunknown1SUPPLYING
WG Critical Care, LLCunknown1SUPPLYING
Hospira, Inc.unknown1SUPPLYING
Gland Pharma Limitedunknown1SUPPLYING
Henry Schein Inc.unknown1SUPPLYING
Civica, Inc.unknown1SUPPLYING
Amneal Pharmaceuticals Private Limitedunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Jan 13, 2022
    SHORTAGEDrug shortage: Metronidazole Injection (InfoRLife SA)

    Metronidazole Injection — reported in shortage by InfoRLife SA. Therapeutic category: Anti-Infective.

  • Jan 13, 2022
    SHORTAGEDrug shortage: Metronidazole Injection (Baxter Healthcare)

    Metronidazole Injection — reported in shortage by Baxter Healthcare. Therapeutic category: Anti-Infective.

  • Jan 13, 2022
    SHORTAGEDrug shortage: Metronidazole Injection (Gland Pharma Limited)

    Metronidazole Injection — reported in shortage by Gland Pharma Limited. Therapeutic category: Anti-Infective.

  • Jan 21, 2016
    RECALLRecall (Class I): Metronidazole Injection USP, 500 mg per 100 mL (5 mg/mL), 100mL Sterile Single Dose Container bag, Rx only, Baxter USA,…

    Presence of Particulate Matter: identified as a cloth fiber. — Recalling firm: Baxter Healthcare Corp. — Nationwide and Puerto Rico

  • May 21, 2013
    RECALLRecall (Class II): Metronidazole Injection USP, RTU, 500 mg/100mL in Viaflex Plus Container, Baxter, Deerfield, IL 60015, NDC 0338-1055-48

    Lack of Assurance of Sterility: Specific lot numbers of these products have been identified for potential administration port leakage. The potential for leakage is the result of a manufacturing issue which occurred during the sealing of the closure assembly at the administration port. — Recalling firm: Baxter Healthcare Corp. — Nationwide & Puerto Rico